• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Closed-loop insulin delivery systems shine at annual diabetes meeting

June 26, 2018 By Sarah Faulkner

diabetesAs device-makers, healthcare practitioners and people with diabetes convened at this year’s annual meeting of the American Diabetes Association, one major theme emerged: the industry is catching on to the potential of closed-loop insulin delivery systems.

Major medical technology companies, including Medtronic and Insulet, touted data at this year’s meeting demonstrating the benefits of their systems that connect glucose monitoring data and insulin dosing. Patient advocacy groups, like the JDRF, have called on the industry to fund and develop automated insulin delivery systems – echoing the calls of a community of people with diabetes that have already been doing this themselves.

Industry players seem to have taken the hint from the diabetes community. Here’s a look at what they’re working on.

NEXT: Medtronic touts real-world outcomes for MiniMed 670G

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Diabeloop, Insulet, Medtronic

IN CASE YOU MISSED IT

  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff

Reader Interactions

Comments

  1. Carolyn says

    August 23, 2018 at 3:26 am

    I am an omnipod user. Just talked to their customer service representative, who knows of no plans to connect a CGMS to an Omnipod.

    Has Insulet’s Omnipod Eros, https://www.drugdeliverybusiness.com/insulet-settles-shareholder-suit-over-omnipod-eros-device/, kept Insulet from pursuing a closed loop system?

    ‘Insulet, touted data at this year’s meeting demonstrating the benefits of their systems that connect glucose monitoring data and insulin dosing’

    • Sarah Faulkner says

      August 23, 2018 at 7:29 am

      Hi Carolyn, thanks for your message! Insulet is developing a system, called the Omnipod Horizon, that is designed to automate insulin delivery. Here’s some more information from Insulet’s CEO: https://www.drugdeliverybusiness.com/how-insulets-ceo-plans-to-create-a-billion-dollar-business/

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS